MARY LONG: Open Payments
NPI 1295877033 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 47 payments from 20 companies in 2025. Trend: 2023 $153 · 2024 $566 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $127 |
| Astellas Pharma US Inc | 4 | $108 |
| Novo Nordisk Inc | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| ViiV Healthcare Company | 3 | $74 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| PFIZER INC. | 2 | $45 |
| Amgen Inc. | 3 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Abbott Laboratories | 2 | $42 |
Products named: DUPIXENT, Veozah, Ozempic, APRETUDE, JARDIANCE, SHINGRIX, TZIELD, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
